Greggs were incredibly proud to once again support the North East Children's Cancer run, where this year over 8,000 runners completed either the 5 mile run or the children's mini 1 mile run.

This year the event celebrated its 35year, and throughout this time has pioneered cancer research in the North East through the following areas:

Clinical Trials

Scientists at Northern Institute for Cancer Research are currently working on clinical trials to develop new therapies to improve survival rates and treatment intensity for patients with Leukaemia.

Individualisation of treatment

NECCR has been researching ways to provide individual treatment to children with an aggressive type of brain cancer to ensure the final outcome is as positive as possible.

New Therapies

Funding from NECCR has been fundamental in the discovery of a less aggressive medical approach to treating childhood Leukaemia's, the most frequent cancers in children.

Thank you to our customers, colleagues and other supporters whose dedication and commitment continue to make this event an incredible success.

Greggs plc published this content on 23 May 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 23 May 2017 15:00:13 UTC.

Original documenthttps://corporate.greggs.co.uk/press-releases/greggs-supports-neccr

Public permalinkhttp://www.publicnow.com/view/845D91652502B6D5BBDAE647BC82F190634BF377